PSTX - Poseida Therapeutics, Inc.
IEX Last Trade
9.43
-0.040 -0.424%
Share volume: 253
Last Updated: Fri 27 Dec 2024 03:30:14 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$9.47
-0.04
-0.42%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-09 | 2024-03-07 | 2024-05-14 | |
| Total revenue | 2.700 M | 116.306 M | 10.051 M | 10.343 M | 20.013 M | 9.352 M | 24.995 M | 28.142 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.700 M | 116.306 M | 10.051 M | 10.343 M | 20.013 M | 9.352 M | 24.995 M | 28.142 M | |
| 4,207.63% | -91.36% | 2.91% | 93.49% | -53.27% | 167.27% | 12.59% | |||
| Operating expenses | 44.245 M | 44.526 M | 43.271 M | 49.859 M | 47.868 M | 45.574 M | 50.906 M | 52.719 M | |
| Selling general and admin | 9.237 M | 9.389 M | 9.367 M | 11.807 M | 8.676 M | 8.092 M | 8.860 M | 9.798 M | |
| Research and development | 35.008 M | 35.137 M | 33.904 M | 38.052 M | 39.192 M | 37.482 M | 42.046 M | 42.921 M | |
| Total expenses | 44.245 M | 44.526 M | 43.271 M | 49.859 M | 47.868 M | 45.574 M | 50.906 M | 52.719 M | |
| 0.64% | -2.82% | 15.22% | -3.99% | -4.79% | 11.70% | 3.56% | |||
| Operating income | -41.545 M | 71.780 M | -33.220 M | -39.516 M | -27.855 M | -36.222 M | -25.911 M | -24.577 M | |
| Ebit | -41.545 M | 71.780 M | -33.220 M | -39.516 M | -27.855 M | -36.222 M | -25.911 M | -24.577 M | |
| Pretax income | -43.036 M | 70.661 M | -33.026 M | -38.847 M | -27.456 M | -31.671 M | -25.349 M | -24.274 M | |
| -264.19% | -146.74% | 17.63% | -29.32% | 15.35% | -19.96% | -4.24% | |||
| Income tax | 0.000 | 252.000 K | 292.000 K | 0.000 | 0.000 | 107.000 K | 0.000 | 0.000 | |
| Net income basic | -43.036 M | 70.409 M | -33.318 M | -38.847 M | -27.456 M | -31.778 M | -25.349 M | -24.274 M | |
| 263.60% | -147.32% | -16.59% | 29.32% | -15.74% | 20.23% | 4.24% | |||
| Net income | -43.036 M | 70.409 M | -33.318 M | -38.847 M | -27.456 M | -31.778 M | -25.349 M | -24.274 M | |
| 263.60% | -147.32% | -16.59% | 29.32% | -15.74% | 20.23% | 4.24% |